30 study sites have been activated (vs. 23 at Q3). Two in the US.
First US patient has not yet been enrolled in the RELEASE study
No update on AZ/fimaNAc or any other deals in the report
Major trigger will be deal/no deal with AstraZeneca, update mid-20
26 Feb 2020
RELEASE study progress is lagging
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
RELEASE study progress is lagging
30 study sites have been activated (vs. 23 at Q3). Two in the US.
First US patient has not yet been enrolled in the RELEASE study
No update on AZ/fimaNAc or any other deals in the report
Major trigger will be deal/no deal with AstraZeneca, update mid-20